Oral therapy for type 1 diabetes mellitus using a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase‐4 inhibitor, examined in non‐obese diabetic mice

Aims/Introduction:  The therapeutic effectiveness against type 1 diabetes mellitus of a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase‐4 inhibitor, was examined in the non‐obese diabetic (NOD) mouse model. Materials and Methods:  Female NOD mice t...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tsuji, Takumi, Yoshida, Yuya, Fujita, Tetsuro, Kohno, Takeyuki
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2012
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4019244/
https://ncbi.nlm.nih.gov/pubmed/24843604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.2040-1124.2012.00218.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky